Literature DB >> 15789135

SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study.

Stefania Battistini1, Fabio Giannini, Giuseppe Greco, Giuseppe Bibbò, Loreta Ferrera, Valeria Marini, Renzo Causarano, Michela Casula, Giuliana Lando, Maria Cristina Patrosso, Claudia Caponnetto, Paola Origone, Alessandro Marocchi, Alberto Del Corona, Gabriele Siciliano, Paola Carrera, Vincenzo Mascia, Marcello Giagheddu, Carlo Carcassi, Sandro Orrù, Cecilia Garrè, Silvana Penco.   

Abstract

Amyotrophic Lateral Sclerosis (ALS), the most common form among motoneuron diseases, is characterized by a progressive neurodegenerative process involving motor neurons in the motor cortex, brain stem and spinal cord. Sporadic (SALS) accounts for the majority of patients but in about 10% of ALS cases the disease is inherited (FALS), usually as an autosomal dominant trait. In the present study we show the results of a referred based multicenter study on the distribution of SOD1 gene mutations in the largest cohort of Italian ALS patients described so far. Two hundred and sixty-four patients (39 FALS and 225 SALS) of Italian origin were studied. In 7 out of 39 FALS patients we found the following SOD1 gene mutations: i) a new G12R missense mutation in exon 1, found in a patient with a slowly progressive disease course; ii) the G41S mutation, in four unrelated patients with rapidly progressive course complicated with cognitive decline in two of them; iii) the L114F mutation, in a patient with a slowly progressive phenotype; iv) the D90A mutation, in a heterozygous patient with atypical phenotype. In addition, in one SALS patient a previously reported synonymous variant S59S was identified. In 17 (3 FALS and 14 SALS) out of 264 patients (6.4 %) the polymorphism A-->C at position 34 of intron 3 (IVS3: + 34 A-->C) was found, and in one FALS patient a novel variant IVS3 + 62 T-->C was identified. The frequency of SOD1 gene mutations (17.9 %) in FALS cases was comparable with that found in other surveys with a similar sample size of ALS cases. No SOD1 gene mutations have been identified in SALS cases. Within FALS cases, The most frequent mutation was the G41S identified in four FALS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15789135     DOI: 10.1007/s00415-005-0742-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  34 in total

1.  Echo of silence: silent mutations, RNA splicing, and neuromuscular diseases.

Authors:  Ami Mankodi; Tetsuo Ashizawa
Journal:  Neurology       Date:  2003-11-25       Impact factor: 9.910

2.  D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype.

Authors:  Matthew J Parton; Wendy Broom; Peter M Andersen; Ammar Al-Chalabi; P Nigel Leigh; John F Powell; Christopher E Shaw
Journal:  Hum Mutat       Date:  2002-12       Impact factor: 4.878

3.  Genetic aspects of amyotrophic lateral sclerosis and progressive bulbar paralysis.

Authors:  W F HABERLANDT
Journal:  Acta Genet Med Gemellol (Roma)       Date:  1959-07

4.  Heterogeneous distribution of amyotrophic lateral sclerosis patients with SOD-1 gene mutations: preliminary data on an Italian survey.

Authors:  A Malaspina; R Zaman; L Mazzini; C Camana; E Poloni; D Curti; M Ceroni
Journal:  J Neurol Sci       Date:  1999-01-15       Impact factor: 3.181

5.  A novel locus for late onset amyotrophic lateral sclerosis/motor neurone disease variant at 20q13.

Authors:  A L Nishimura; M Mitne-Neto; H C A Silva; J R M Oliveira; M Vainzof; M Zatz
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

6.  Epidemiologic study of amyotrophic lateral sclerosis in Sardinia, Italy.

Authors:  M Giagheddu; G Puggioni; C Masala; F Biancu; G Pirari; M R Piras; M G Rachele
Journal:  Acta Neurol Scand       Date:  1983-12       Impact factor: 3.209

7.  Identification of two novel mutations and a new polymorphism in the gene for Cu/Zn superoxide dismutase in patients with amyotrophic lateral sclerosis.

Authors:  J Esteban; D R Rosen; A C Bowling; P Sapp; D McKenna-Yasek; J P O'Regan; M F Beal; H R Horvitz; R H Brown
Journal:  Hum Mol Genet       Date:  1994-06       Impact factor: 6.150

8.  A screening for superoxide dismutase-1 D90A mutation in Italian patients with sporadic amyotrophic lateral sclerosis.

Authors:  Michelangelo Mancuso; Massimiliano Filosto; Ali Naini; Anna Rocchi; Alberto Del Corona; Ferdinando Sartucci; Gabriele Siciliano; Luigi Murri
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2002-12

9.  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2.

Authors:  S Hadano; C K Hand; H Osuga; Y Yanagisawa; A Otomo; R S Devon; N Miyamoto; J Showguchi-Miyata; Y Okada; R Singaraja; D A Figlewicz; T Kwiatkowski; B A Hosler; T Sagie; J Skaug; J Nasir; R H Brown; S W Scherer; G A Rouleau; M R Hayden; J E Ikeda
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

10.  SOD1 missense mutation in an Italian family with ALS.

Authors:  I Rainero; L Pinessi; T Tsuda; M G Vignocchi; G Vaula; L Calvi; P Cerrato; B Rossi; L Bergamini; D R McLachlan
Journal:  Neurology       Date:  1994-02       Impact factor: 9.910

View more
  32 in total

Review 1.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

Review 2.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

Review 3.  Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

Authors:  Peter M Andersen; Ammar Al-Chalabi
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

4.  The distinct genetic pattern of ALS in Turkey and novel mutations.

Authors:  Aslıhan Özoğuz; Özgün Uyan; Güneş Birdal; Ceren Iskender; Ece Kartal; Suna Lahut; Özgür Ömür; Zeynep Sena Agim; Aslı Gündoğdu Eken; Nesli Ece Sen; Pınar Kavak; Ceren Saygı; Peter C Sapp; Pamela Keagle; Yeşim Parman; Ersin Tan; Filiz Koç; Feza Deymeer; Piraye Oflazer; Haşmet Hanağası; Hakan Gürvit; Başar Bilgiç; Hacer Durmuş; Mustafa Ertaş; Dilcan Kotan; Mehmet Ali Akalın; Halil Güllüoğlu; Mehmet Zarifoğlu; Fikret Aysal; Nilgün Döşoğlu; Kaya Bilguvar; Murat Günel; Özlem Keskin; Tahsin Akgün; Hilmi Özçelik; John E Landers; Robert H Brown; A Nazlı Başak
Journal:  Neurobiol Aging       Date:  2015-01-10       Impact factor: 4.673

5.  Phenotypic heterogeneity in a SOD1 G93D Italian ALS family: an example of human model to study a complex disease.

Authors:  Silvana Penco; Christian Lunetta; Lorena Mosca; Eleonora Maestri; Francesca Avemaria; Claudia Tarlarini; Maria Cristina Patrosso; Alessandro Marocchi; Massimo Corbo
Journal:  J Mol Neurosci       Date:  2010-12-01       Impact factor: 3.444

Review 6.  The frontotemporal syndromes of ALS. Clinicopathological correlates.

Authors:  Michael Joseph Strong; Wencheng Yang
Journal:  J Mol Neurosci       Date:  2011-08-02       Impact factor: 3.444

7.  An Italian kindred with FALS due to c.149T>C mutation in the SOD1 gene: case report of an affected family member.

Authors:  Francesca Trojsi; Giovanni Piccirillo; Cinzia Femiano; Raffaele Damiano; Maria Rosaria Monsurrò
Journal:  Acta Myol       Date:  2013-05

Review 8.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

Review 9.  Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Authors:  Hiroko Kishikawa; David Wu; Guo-fu Hu
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

10.  Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis.

Authors:  David Wu; Wenhao Yu; Hiroko Kishikawa; Rebecca D Folkerth; A John Iafrate; Yiping Shen; Winnie Xin; Katherine Sims; Guo-Fu Hu
Journal:  Ann Neurol       Date:  2007-12       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.